Bixiye
P40-16 New Drug-Related Prior Authorization Criteria with Quantity Limit for Lidocaine Transdermal
Taariikhda barnaamijka Dhaqangalayso Agosto 03, 2016
Natiijooyinka Raadinta
Soo bandhiga 3241 - 3250 ee natiijooyinka 3688
Bixiye
P44-16 Addition of a Drug (Viekira XR) to the Hepatitis C Second Generation Prior Authorization with Quantity Limit Program
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2016
Bixiye
P47-17 Change to the Requirement to Submit National Drug Codes
Taariikhda barnaamijka Dhaqangalayso Agosto 23, 2017
Bixiye
P36-16 Case Management (T1016) Billing for Tuberculosis Related Services for Government Programs Subscribers
Taariikhda dhaqangalka Barnaamijka: Jul 27, 2016
Bixiye
P41-16 Live Attenuated Influenza Vaccine (LAIV) Will Not Be Covered During the 2016-2017 Flu Season
Taariikhda barnaamijka Dhaqangalayso Agosto 03, 2016
Bixiye
P10-17 Changes in Medical Policy IV-122 Knee Arthroplasty (Knee Replacement)
Taariikhda uu dhaqangalayo Barnaamijka: Mar 24, 2017
Bixiye
P5-18 New Medical Drug-Related PA Requirements for Yescarta and Kymriah
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2018
Bixiye
P32-16 New Drug-Related Prior Authorization Criteria with Quantity Limit for Kuvan
Taariikhda dhaqangalka Barnaamijka: Jul 27, 2016
Bixiye
P42-16 Change in Medical Policy and Commercial Benefit Coverage of Cologuard Colorectal Cancer Screening Test
Taariikhda barnaamijka Dhaqangalayso Agosto 08, 2016
Bixiye
P1-17 Prior Authorization Requirement for Gender Dysphoria
Taariikhda uu dhaqangalayo Barnaamijka: Jan 18, 2017